A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-17
DOI
10.3389/fonc.2021.634881
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SOAT1 promotes mevalonate pathway dependency in pancreatic cancer
- (2020) Tobiloba E. Oni et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer
- (2020) Hang-Ping Yao et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol
- (2020) Mary W Redman et al. LANCET ONCOLOGY
- SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models
- (2019) Chang-yong Yang et al. ACTA PHARMACOLOGICA SINICA
- SHR ‐A1403, a novel c‐mesenchymal‐epithelial transition factor (c‐Met) antibody‐drug conjugate, overcomes AZD 9291 resistance in non‐small cell lung cancer cells overexpressing c‐Met
- (2019) Mengya Tong et al. CANCER SCIENCE
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival
- (2018) Su Jin Lee et al. Clinical Colorectal Cancer
- Therapeutic developments in pancreatic cancer: current and future perspectives
- (2018) John P. Neoptolemos et al. Nature Reviews Gastroenterology & Hepatology
- First-in-Human Phase I, Dose-Escalation and -Expansion Study of Telisotuzumab Vedotin, an Antibody–Drug Conjugate Targeting c-Met, in Patients With Advanced Solid Tumors
- (2018) John H. Strickler et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical pharmacokinetics of a novel anti-c-Met antibody–drug conjugate, SHR-A1403, in rodents and non-human primates
- (2018) Changyong Yang et al. XENOBIOTICA
- MET in Lung Cancer: Biomarker Selection Based on Scientific Rationale
- (2017) Ravi Salgia MOLECULAR CANCER THERAPEUTICS
- Cholesterol Modification of Smoothened Is Required for Hedgehog Signaling
- (2017) Xu Xiao et al. MOLECULAR CELL
- Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review
- (2017) Jung Han Kim et al. Oncotarget
- Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a meta-analysis
- (2017) Jung Han Kim et al. Oncotarget
- Key role of pancreatic stellate cells in pancreatic cancer
- (2016) Srinivasa P. Pothula et al. CANCER LETTERS
- ABBV-399, a c-Met Antibody–Drug Conjugate that Targets Both MET –Amplified and c-Met–Overexpressing Tumors, Irrespective of MET Pathway Dependence
- (2016) Jieyi Wang et al. CLINICAL CANCER RESEARCH
- Antibody–drug conjugates for cancer therapy
- (2016) Anish Thomas et al. LANCET ONCOLOGY
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation
- (2014) Amr A. Al-Haidari et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors
- (2014) Elizabeth Smyth et al. OncoTargets and Therapy
- Cholesterol selectively activates canonical Wnt signalling over non-canonical Wnt signalling
- (2014) Ren Sheng et al. Nature Communications
- Epidemiology, risk factors, and the promotion of pancreatic cancer: Role of the stellate cell
- (2012) Stephen Pandol et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
- (2012) Mert Erkan et al. Nature Reviews Gastroenterology & Hepatology
- Epidemiology of Pancreatic Cancer: An Update
- (2010) Patrick Maisonneuve et al. DIGESTIVE DISEASES
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MET as a target for treatment of chest tumors
- (2008) Nicole A. Cipriani et al. LUNG CANCER
- Drug development of MET inhibitors: targeting oncogene addiction and expedience
- (2008) Paolo M. Comoglio et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More